These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25079569)

  • 1. Human leukocyte antigen genotypes and trial of desensitization in patients with oxcarbazepine-induced skin rash: a pilot study.
    Lee B; Yu HJ; Kang ES; Lee M; Lee J
    Pediatr Neurol; 2014 Aug; 51(2):207-14. PubMed ID: 25079569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine sensitivity treated by desensitisation.
    Watts D; Bird J
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):376. PubMed ID: 1829110
    [No Abstract]   [Full Text] [Related]  

  • 3. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization to Oxcarbazepine: Long-Term Efficacy and Tolerability.
    Lee J; Park EG; Lee M; Lee J
    J Clin Neurol; 2017 Jan; 13(1):47-54. PubMed ID: 27730770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience.
    Kothare SV; Khurana DS; Mostofi N; Melvin JJ; Marks HG; Valencia I; Legido A
    Pediatr Neurol; 2006 Oct; 35(4):235-9. PubMed ID: 16996394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful induction of tolerance in an epilepsy patient with phenobarbital allergy].
    Fröscher W; Kleinhans D
    Nervenarzt; 1998 Feb; 69(2):158-61. PubMed ID: 9551461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
    Gaily E; Granström ML; Liukkonen E
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():41-5. PubMed ID: 10030431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of oxcarbazepine oral suspension in childhood epilepsy: open-label study.
    Rufo-Campos M; Casas-Fernández C; Martínez-Bermejo A
    J Child Neurol; 2006 Jun; 21(6):480-5. PubMed ID: 16948931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug.
    Klassen BD; Sadler RM
    Epilepsia; 2001 Mar; 42(3):433-5. PubMed ID: 11442165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
    Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical aspects of oxcarbazepine treatment.
    Dam M
    Epilepsia; 1994; 35 Suppl 3():S23-5. PubMed ID: 8156977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Oct; 28(10):1211-4. PubMed ID: 18823216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of the first antiepileptic drug in children with newly diagnosed idiopathic epilepsy.
    Yılmaz U; Yılmaz TS; Dizdarer G; Akıncı G; Güzel O; Tekgül H
    Seizure; 2014 Apr; 23(4):252-9. PubMed ID: 24370319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine in the treatment of early childhood epilepsy.
    Gaily E; Granström ML; Liukkonen E
    J Child Neurol; 1997 Nov; 12(8):496-8. PubMed ID: 9430314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations.
    Alldredge BK; Knutsen AP; Ferriero D
    Pediatr Neurol; 1994 Mar; 10(2):169-71. PubMed ID: 8024670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxcarbazepine therapy in very young children: a single-center clinical experience.
    Kothare SV; Mostofi N; Khurana DS; Mohsem B; Melvin JJ; Hardison HH; Valencia I; Legido A
    Pediatr Neurol; 2006 Sep; 35(3):173-6. PubMed ID: 16939855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxcarbazepine in the treatment of childhood epilepsy.
    Serdaroglu G; Kurul S; Tutuncuoglu S; Dirik E; Sarioglu B
    Pediatr Neurol; 2003 Jan; 28(1):37-41. PubMed ID: 12657418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment.
    Friis ML; Kristensen O; Boas J; Dalby M; Deth SH; Gram L; Mikkelsen M; Pedersen B; Sabers A; Worm-Petersen J
    Acta Neurol Scand; 1993 Mar; 87(3):224-7. PubMed ID: 8475694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.